ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Patient Advocacy: Survivorship Programs Win Funds To form Model Programs

December 13, 1996

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

Preventive Oncology Announcement Withdrawn For Modification

April 3, 1981

Advisors Approve CCOP, EDRN, Pediatric Brain Tumor Network Renewal

March 28, 2003

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004